Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events ??? Agreement to Sell Assets of Clinical Labs Division to Labcorp (Details)

v3.23.1
Subsequent Events – Agreement to Sell Assets of Clinical Labs Division to Labcorp (Details)
6 Months Ended
Jan. 31, 2023
USD ($)
Subsequent Events [Abstract]  
Cash $ 146,000,000
Shares outstanding rate 11.00%
Termination fee $ 5,000,000
Reimbursement of buyer’s expenses $ 5,000,000